📌Curious about: How metal exposure affects the #Metallome & #Lipidome in C.elegans and how this relates to neurodegenerative diseases, such as Parkinson?
💡Check out our latest publication
🔄Bastian Blume @Schmitt_Kopplin@HelmholtzMunich@WWU_Muenster ⬇️ https://t.co/Avs63nlwVp
📌Still looking for an easy & robust method for analyzing free glycation products?
💡Please check out our latest paper about #HILIC-MS for untargeted profiling free #glycation products diversity
⬇️
https://t.co/gmTZG0OrOO
🔄@yan_yingfei@DHemmler@Schmitt_Kopplin@HelmholtzMunich
📌Post-COVID-19 syndrome? Look into my eyes!
💡Retinal microcirculation as objective #biomarker for chronic fatigue assessment in patients with #post-COVID syndrome.
🔄@marianna_lucio @Dr_B_Hohberger@HelmholtzMunich@UniFAU
➡️https://t.co/DSCVjlq43n
📌 Microbial metabolites in urine samples?
💡Our urine #NMR 🧲metabolomics workflow with metabolite identification developments shows how we can characterize microbial vs endogenous metabolites
🔄@ssHeinzmann@Schmitt_Kopplin@EPI_Helmholtz@HelmholtzMunich
⬇️
We are at #cac2022 !
Please visit 🤝 Erwin Kupczyk at his Poster P17 📜 and chat 🗣 with him about „Benchmarking Machine Learning Approaches for Hit Detection in High-Content Screening“💡 @stanze_@HelmholtzMunich
📌Diabetes drug discovery with high-content screening?
💡 Please check out our latest review describing combination of #HCS and untargeted #metabolomics to ameliorate early stage screening of #T2DM drugs
🔄@stanze_@Schmitt_Kopplin@HelmholtzMunich
⬇️
https://t.co/TdyQv84SQs